Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
All BC9 research compounds undergo trusted third-party lab testing by accredited laboratories
Research Focus: It is being studied primarily for the treatment of obesity , type 2 diabetes , and fatty liver disease (MASH/MASLD).
Preliminary research suggests that L-carnitine might help maintain healthy blood sugar levels and improve insulin sensitivity in people with diabetes [7]
As of early 2026, retatrutide is not FDA-approved and cannot be legally prescribed
pigmentation improves gradually
Trial data consistently show the combination arms exceeding cagrilintide-alone arms 15.6% vs 8.1% at 32 weeks in the Phase 2 diabetes trial (Frias et al., 2023), and a 22.7% combination figure at 68 weeks in REDEFINE 1 (Aronne et al., 2025)
US$ 28.86
US$ 28.16
US$ 26.76
US$ 24.29
